person
Gregory P.
- Country
- France
- Department
- Service de Médecine Interne et Immunologie Clinique
Research Overview
assignment
49
Clinical Trials ·
- Evaluation of CNTY-101, a CD19-targeted CAR iNK Cell Therapy, in Refractory Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, and Diffuse Cutaneous Systemic Sclerosis
- Phase 1 Study on Safety and Preliminary Efficacy of CTX112 in Adults with Refractory Systemic Lupus Erythematosus, Systemic Sclerosis, or Idiopathic Inflammatory Myopathy
- Long-Term Follow-up Study of Century Therapeutics Cellular Therapy in Hematological Malignancies, Solid Tumors, and Autoimmune Diseases
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
232
Sites with multiple studies
Has run more than one trial at 232 of 477 partner sites.
Specializations
Systemic Sclerosis Research
Specializes in investigating innovative treatments for diffuse cutaneous systemic sclerosis and its complications, with particular attention to interstitial lung disease associated manifestations.
- Digital ulcer healing interventions
- Lung function preservation strategies
- Novel therapeutic approaches
Autoimmune Conditions
Conducts research on various systemic autoimmune disorders, including lupus nephritis and inflammatory myopathies.
- Systemic Lupus Erythematosus treatments
- Vasculitis management
- Inflammatory myopathy therapies
Inflammatory Diseases
Focuses on treating complex inflammatory conditions including eosinophilic granulomatosis and uveitis.
- Behçet's disease interventions
- Giant cell arteritis treatments
- ANCA-associated vasculitis therapies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.